Journal article
Long-term follow-up of smokers following lung and colorectal cancer diagnosis
Supportive care in cancer, Vol.30(9), pp.7801-7809
09/01/2022
DOI: 10.1007/s00520-022-07111-5
PMID: 35552828
Abstract
Background Continued smoking after a cancer diagnosis limits the effectiveness of treatment, increases the risk of cancer recurrence or secondary malignancies, and is associated with poorer quality of life and survival. A cancer diagnosis may provide a meaningful timepoint for quitting, but the prevalence and characteristics of continued smoking through survivorship are poorly understood. Methods In the multi-regional Cancer Care Outcomes Research and Surveillance (CanCORS) cohort, we examined smoking rates and factors associated with continued smoking at long-term follow-up among lung and colorectal cancer patients. This paper builds upon previous CanCORS participant data addressing quit rates and associated characteristics at baseline and 5 months post-diagnosis. Results At long-term follow-up (median 7.3 years post-diagnosis [IQR = 5.9-8.7]), 16.7% of lung cancer and 11.6% of colorectal cancer survivors continued to smoke combustible cigarettes. Factors independently associated with continued smoking at long-term follow-up included being male, younger, not married or partnered, having Medicare, Medicaid/other public or no insurance, more depression symptoms, smoking more cigarettes per day, and having a history of lung disease (p < .05). Continued smoking did not vary by lung vs. colorectal cancer diagnosis. Conclusion Of active smokers at the time of diagnosis, an important minority of lung and colorectal cancer survivors continued to smoke well into survivorship. Understanding characteristics associated with continued smoking after a cancer diagnosis may help inform the development of tobacco treatment programs for cancer patients and survivors. Implications for survivors While addressing smoking cessation at the time of diagnosis is critical to ensure better long-term treatment outcomes and quality of life, it is essential to continue smoking cessation discussions and efforts throughout care and survivorship.
Details
- Title: Subtitle
- Long-term follow-up of smokers following lung and colorectal cancer diagnosis
- Creators
- Elyse R. Park - Massachusetts General HospitalSarah E. Skurla - Dept Vet Affairs, Ctr Clin Management Res, Ann Arbor, MI USAGrelda Yazmin Juarez Caballero - Univ Iowa, Ctr Publ Hlth Stat, Coll Publ Hlth, Iowa City, IA USAEmily R. Friedman - Massachusetts Gen Hosp, Hlth Policy Res Ctr, Mongan Inst, 100 Cambridge St,Suite 1600, Boston, MA 02114 USAColin Ponzani - Massachusetts Gen Hosp, Hlth Policy Res Ctr, Mongan Inst, 100 Cambridge St,Suite 1600, Boston, MA 02114 USARobert Wallace - University of Iowa, EpidemiologyJennifer Malin - OptumNancy L. Keating - Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA
- Resource Type
- Journal article
- Publication Details
- Supportive care in cancer, Vol.30(9), pp.7801-7809
- DOI
- 10.1007/s00520-022-07111-5
- PMID
- 35552828
- NLM abbreviation
- Support Care Cancer
- ISSN
- 0941-4355
- eISSN
- 1433-7339
- Publisher
- Springer Nature
- Number of pages
- 9
- Grant note
- U01 CA093332; U01 CA093324; U01 CA093348; U01 CA093329; U01 CA093339; U01 CA093326; CRS 02-164; U01 CA093344 / NCI; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) Park MSRG 005-05-CPPB / ACS; American Cancer Society
- Language
- English
- Date published
- 09/01/2022
- Academic Unit
- Epidemiology; Injury Prevention Research Center; Internal Medicine
- Record Identifier
- 9984364454902771
Metrics
9 Record Views